SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BSD Medical (Long Term Investment Oriented)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: pleonastic1/17/2013 4:50:02 PM
1 Recommendation   of 178
 
Something that I have addressed before needs continual repeating – because it seems not to register:

BSD Medical has developed and has introduced/is introducing a whole new cancer therapy methodology. So, I will continue to harp on this key fact and why I continues to be ignored by the bulk of medical-therapy-company investors.



What I mean by the above, particularly re chemotherapy, is that – instead of being applicable only to one or another cancer -- microwave electrohyperthermia and microwave ablation are very effective for a wide range of cancers! Granted, “full” coverage of all cancers by microwave therapy takes more than one type of machine, but this is nothing like chemo-therapy, which takes many drugs to cover the same range of cancers. For investors in emerging cancer-treatment companies, this means that BSDM offers far more potential than any one emerging chemo-therapy company. And, from theory and the highly positive results of many Phase3 trials and actual practice -- the “potential” has IMO become a rather solid projection.



So, why should the stock market not, by now, have responded to BSD Medical as much as the TOTAL of ALL new-drug companies!? Ignorance is the culprit! Consider: New cancer drugs typically fail – sooner or later. But, aside from some initial, decades-ago misapplications, microwave electrohyperthermia and ablation have typically succeeded very well! – for a *wide range* of cancers. Only a lack of intelligent awareness of these things – among doctors, patients, and investors -- can explain why microwave heating therapy and BSD M have not yet burgeoned. But, this situation appears to be near an end – BSD M appears poised for blooming!



Not only does microwave therapy (the outstandingly best type of hyperthermia) work very well, it lacks the inherent miseries and hazards of surgery, radiotherapy, and chemotherapy. Surgery is typically traumatic (older patients often are denied surgery!) and disfiguring and conducive to spreading cancer cells (aiding metastasizing). Radiotherapy is also conducive to CAUSING cancers, and it is very difficult to fully kill all the cells in a tumor with ionizing radiation (and, more healthy cells are typically killed than tumor cells). Chemotherapy typically has horrible side effects, and death for all cancer cells is definitely chancy. While microwave heat-therapy is not perfect, it offers better efficacy and is noninvasive and has no inherent hazards (given careful technique). So, I say widespread use of microwave heating is a given! Timeline? That’s anyone’s guess, but its use is “heating up” (a term used in an article on the subject). And, BSD Medical is the clear world leader in electrohyperthermia and ablation.



To add to the rosy outlook, hyperthermia (and microwave hyperthermia is generally the best, by far) is strongly effective for adjuvant (aiding) use with surgery, radiotherapy, and chemotherapy.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext